These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 24336709)
1. Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro. Li X; Zhang X; Ladiwala AR; Du D; Yadav JK; Tessier PM; Wright PE; Kelly JW; Buxbaum JN J Neurosci; 2013 Dec; 33(50):19423-33. PubMed ID: 24336709 [TBL] [Abstract][Full Text] [Related]
2. Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective? Li X; Masliah E; Reixach N; Buxbaum JN J Neurosci; 2011 Aug; 31(35):12483-90. PubMed ID: 21880910 [TBL] [Abstract][Full Text] [Related]
3. Transthyretin Suppresses Amyloid-β Secretion by Interfering with Processing of the Amyloid-β Protein Precursor. Li X; Song Y; Sanders CR; Buxbaum JN J Alzheimers Dis; 2016 Apr; 52(4):1263-75. PubMed ID: 27079720 [TBL] [Abstract][Full Text] [Related]
4. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model. Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237 [TBL] [Abstract][Full Text] [Related]
5. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease. Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966 [TBL] [Abstract][Full Text] [Related]
6. The inhibition of cellular toxicity of amyloid-β by dissociated transthyretin. Cao Q; Anderson DH; Liang WY; Chou J; Saelices L J Biol Chem; 2020 Oct; 295(41):14015-14024. PubMed ID: 32769117 [TBL] [Abstract][Full Text] [Related]
7. Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease? Li X; Buxbaum JN Mol Neurodegener; 2011 Nov; 6():79. PubMed ID: 22112803 [TBL] [Abstract][Full Text] [Related]
8. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease. Alemi M; Silva SC; Santana I; Cardoso I CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028 [TBL] [Abstract][Full Text] [Related]
9. Transthyretin variants with improved inhibition of β-amyloid aggregation. Mangrolia P; Yang DT; Murphy RM Protein Eng Des Sel; 2016 Jun; 29(6):209-218. PubMed ID: 27099354 [TBL] [Abstract][Full Text] [Related]
10. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). Choi SH; Leight SN; Lee VM; Li T; Wong PC; Johnson JA; Saraiva MJ; Sisodia SS J Neurosci; 2007 Jun; 27(26):7006-10. PubMed ID: 17596449 [TBL] [Abstract][Full Text] [Related]
11. The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice. Wang X; Cattaneo F; Ryno L; Hulleman J; Reixach N; Buxbaum JN J Neurosci; 2014 May; 34(21):7253-65. PubMed ID: 24849358 [TBL] [Abstract][Full Text] [Related]
12. Transthyretin as both a sensor and a scavenger of β-amyloid oligomers. Yang DT; Joshi G; Cho PY; Johnson JA; Murphy RM Biochemistry; 2013 Apr; 52(17):2849-61. PubMed ID: 23570378 [TBL] [Abstract][Full Text] [Related]
14. Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis. Silva CS; Eira J; Ribeiro CA; Oliveira Â; Sousa MM; Cardoso I; Liz MA Neurobiol Aging; 2017 Nov; 59():10-14. PubMed ID: 28780366 [TBL] [Abstract][Full Text] [Related]
15. Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1? Alemi M; Gaiteiro C; Ribeiro CA; Santos LM; Gomes JR; Oliveira SM; Couraud PO; Weksler B; Romero I; Saraiva MJ; Cardoso I Sci Rep; 2016 Feb; 6():20164. PubMed ID: 26837706 [TBL] [Abstract][Full Text] [Related]
16. Rare Genetic Variants of the Transthyretin Gene Are Associated with Alzheimer's Disease in Han Chinese. Xiang Q; Bi R; Xu M; Zhang DF; Tan L; Zhang C; Fang Y; Yao YG Mol Neurobiol; 2017 Sep; 54(7):5192-5200. PubMed ID: 27562180 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of amyloid beta fibril formation by monomeric human transthyretin. Garai K; Posey AE; Li X; Buxbaum JN; Pappu RV Protein Sci; 2018 Jul; 27(7):1252-1261. PubMed ID: 29498118 [TBL] [Abstract][Full Text] [Related]
18. Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants. Schwarzman AL; Tsiper M; Wente H; Wang A; Vitek MP; Vasiliev V; Goldgaber D Amyloid; 2004 Mar; 11(1):1-9. PubMed ID: 15185492 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the interaction of β-amyloid with transthyretin monomers and tetramers. Du J; Murphy RM Biochemistry; 2010 Sep; 49(38):8276-89. PubMed ID: 20795734 [TBL] [Abstract][Full Text] [Related]
20. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro. Cascella R; Conti S; Mannini B; Li X; Buxbaum JN; Tiribilli B; Chiti F; Cecchi C Biochim Biophys Acta; 2013 Dec; 1832(12):2302-14. PubMed ID: 24075940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]